STAT

Experts chart the path forward to recruit and advance more women in science

“Women can sit in a room and talk for days — for years — about how we can advocate for change. But until the broader system [adopts] some of those…

Science, medicine, and academia are increasingly grappling with obstacles that can block women from advancing their careers and feeling comfortable in the workplace. Women in science say change is urgently needed — from the board room to the lab bench.

That was the message at a panel on the path forward for women in science on Tuesday, convened by

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Wegovy And Ozempic Sales, Rising Pharma Layoffs, And More
Sales of the blockbuster Wegovy obesity treatment more than doubled in the first quarter as Novo Nordisk races to make more of the drug to meet surging demand.
STAT2 min readAmerican Government
STAT+: Pharmalittle: We’re Reading About FTC Reviewing Novo-Catalent Deal, Amneal Opioid Settlement, And More
The FTC wants more information on a $16.5 million deal in which Novo Nordisk's parent company would purchase Catalent, a contract drug manufacturer.

Related Books & Audiobooks